Dectin-1 and Immunity Against Pneumocystis Carinii
Dectin-1 和卡氏肺孢子虫免疫
基本信息
- 批准号:7516394
- 负责人:
- 金额:$ 28.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-05-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdenovirusesAdoptive TransferAlveolar MacrophagesAntigen PresentationAntigensAppendixAreaBiological AssayCXC ChemokinesCarbohydratesCellsChadCharacteristicsChimeric ProteinsCoculture TechniquesDataDendritic CellsEnvironmentEquilibriumEventExcisionGlucansGuanine Nucleotide Dissociation InhibitorsHost DefenseHost Defense MechanismHumanITAMImmuneImmune responseImmune systemImmunityImmunocompromised HostImmunotherapeutic agentIn VitroIndividualInfectionInflammationInflammatoryInflammatory ResponseInjuryInterleukin-6InterruptionInvadedKnockout MiceLeadLectinLinkLungLymphoid TissueMediatingModelingMusMutateNatural ImmunityOrganismPathogenesisPathway interactionsPhagocytesPlayPneumocystis cariniiPneumoniaPolymerase Chain ReactionPredispositionProductionProliferatingProtein Tyrosine KinaseResearch PersonnelRoleSignal TransductionSiteSplenocyteSystemT-Cell ActivationT-LymphocyteTestingTimeTinTissuesToll-Like Receptor 2Tumor Necrosis Factor-alphabasebeta-Glucansbeta-glucan receptorchemokineconceptcytokinedectin 1extracellularhigh throughput screeningin vivoin vivo Modelinsightkillingslung injurymacrophagemacrophage inflammatory protein 2mannose receptormolecular recognitionmutantnovelpathogenprogramsreceptorreconstitutionresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): Elimination of Pneumocystis carinii, a significant cause of pneumonia in immunocompromised individuals, from the pulmonary environment is the exclusive responsibility of the alveolar macrophage. However, due to P. carinii's inability to be stably cultured in vitro, to date, there has been no high-throughput assay of viability to elucidate innate cell-mediated host defense mechanisms against P. carinii. Using a novel in vitro killing assay, we discovered that recognition and subsequent non-opsonic killing of P. carinii by alveolar macrophages occurs via a newly described receptor for fungal beta-glucans, Dectin-1. Dectin-1 is a 28 kDa, type II transmembrane receptor that contains a single lectin-like carbohydrate recognition domain which recognizes beta 1,3-linked and beta 1,6-linked glucans. We also observed that the alveolar macrophage inflammatory response to P. carinii is mediated by Dectin-1 recognition. We further show that immature lung-derived dendritic cells express high levels of Dectin-1. Based on these studies, we hypothesize that Dectin-1 is required for non-opsonic alveolar macrophage effector function against P. carinii as well as dendritic cell-mediated activation of adaptive T cell responses against P. carinii. We will test this hypothesis with the following specific aims. Specific Aim 1: To test the concept that Dectin-1 mediated recognition of P. carinii is critical for alveolar macrophage host defense against P. carinii in vitro. Specific Aim 2: To test the concept that beta-glucan recognition is required for P. carinii-induced pulmonary inflammation. Specific Aim 3: To test the concept that interruption of Dectin-1 mediated P. carinii recognition increases susceptibility to lung infection with P. carinii. These studies will investigate a new fungal molecular recognition receptor and characterize its role, in vitro as well as in vivo, against the opportunistic fungal organism P. carinii and may provide new insight into how P. carinii is recognized by the immune system, which may lead to novel immunotherapeutic strategies to combat this devastating pulmonary infection.
描述(由申请人提供):从肺环境中消除卡氏肺孢子虫(免疫功能低下个体肺炎的重要原因)是肺泡巨噬细胞的唯一责任。 然而,由于卡氏肺孢子虫不能在体外稳定培养,迄今为止,还没有高通量的生存力测定来阐明针对卡氏肺孢子虫的先天性细胞介导的宿主防御机制。使用一种新的体外杀伤试验,我们发现肺泡巨噬细胞对卡氏肺孢子虫的识别和随后的非调理素杀伤是通过一种新描述的真菌β-葡聚糖受体Dectin-1发生的。 Dectin-1是一种28 kDa的II型跨膜受体,含有单个凝集素样碳水化合物识别结构域,其识别β 1,3-连接和β 1,6-连接的葡聚糖。 我们还观察到肺泡巨噬细胞对卡氏肺孢子虫的炎症反应由Dectin-1识别介导。 我们进一步表明,未成熟的肺源性树突状细胞表达高水平的Dectin-1。 基于这些研究,我们假设Dectin-1是针对卡氏肺孢子虫的非调理素肺泡巨噬细胞效应子功能以及树突状细胞介导的针对卡氏肺孢子虫的适应性T细胞应答的活化所必需的。我们将通过以下具体目标来检验这一假设。 具体目标1:检测Dectin-1介导的卡氏肺孢子虫识别对于肺泡巨噬细胞宿主体外防御卡氏肺孢子虫至关重要的概念。 具体目标2:检验卡氏肺孢子虫诱导的肺部炎症需要β-葡聚糖识别的概念。 具体目标3:为了测试中断Dectin-1介导的卡氏肺孢子虫识别增加卡氏肺孢子虫肺部感染易感性的概念。 这些研究将研究一种新的真菌分子识别受体,并在体外和体内表征其对机会性真菌生物卡氏肺孢子虫的作用,并可能为卡氏肺孢子虫如何被免疫系统识别提供新的见解,这可能导致新的免疫策略来对抗这种毁灭性的肺部感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chad Steele其他文献
Chad Steele的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chad Steele', 18)}}的其他基金
Biology of innate IL-22 during lung fungal infection
肺部真菌感染期间先天性 IL-22 的生物学
- 批准号:
10643901 - 财政年份:2017
- 资助金额:
$ 28.37万 - 项目类别:
Biology of innate IL-22 during lung fungal infection
肺部真菌感染期间先天性 IL-22 的生物学
- 批准号:
10316508 - 财政年份:2017
- 资助金额:
$ 28.37万 - 项目类别:
Biology of innate IL-22 during lung fungal infection
肺部真菌感染期间先天性 IL-22 的生物学
- 批准号:
10474632 - 财政年份:2017
- 资助金额:
$ 28.37万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 28.37万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 28.37万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 28.37万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 28.37万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 28.37万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 28.37万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 28.37万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 28.37万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 28.37万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 28.37万 - 项目类别: